United Kingdom

People: Biogen Inc (BIIB.OQ)

BIIB.OQ on NASDAQ Stock Exchange Global Select Market

3:46pm BST
Change (% chg)

$-1.13 (-0.49%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Sandrock, Alfred 

Dr. Alfred W. Sandrock, Jr. M.D. Ph.D. has served as an Executive Vice President and Chief Medical Officer of Biogen Inc. since October 2017. rior to that, Dr. Sandrock served as our Executive Vice President, Chief Medical Officer Neurology and Neurodegeneration from October 2015 to October 2017, as our Chief Medical Officer and Group Senior Vice President from April 2013 to October 2015 and as our Chief Medical Officer and Senior Vice President of Development Sciences from February 2012 to April 2013. Prior to that, Dr. Sandrock held several other senior executive positions since joining Biogen in 1998, including Senior Vice President of Neurology Research and Development and Vice President of Clinical Development, Neurology.

Basic Compensation

Total Annual Compensation, USD 1,160,130
Restricted Stock Award, USD 6,820,260
Long-Term Incentive Plans, USD --
All Other, USD 188,997
Fiscal Year Total, USD 8,169,380

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --